Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
1.750
-0.060 (-3.31%)
At close: Jun 6, 2025, 4:00 PM
1.830
+0.080 (4.57%)
After-hours: Jun 6, 2025, 5:23 PM EDT

Aprea Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
19.2822.8521.6128.7953.08-
Cash & Short-Term Investments
19.2822.8521.6128.7953.08-
Cash Growth
-40.45%5.75%-24.94%-45.76%--
Prepaid Expenses
0.560.730.911.373.51-
Total Current Assets
19.8323.5822.5230.1556.58-
Property, Plant & Equipment
0.080.080.0900.21-
Other Long-Term Assets
0.310.320.04-0.03-
Total Assets
20.2223.9822.6530.1656.82-
Accounts Payable
1.281.351.670.841.77-
Accrued Expenses
2.082.012.192.365.35-
Current Portion of Leases
----0.19-
Current Unearned Revenue
--0.53---
Total Current Liabilities
3.363.364.393.27.32-
Total Liabilities
3.363.364.393.27.32-
Common Stock
0.010.01000-
Additional Paid-In Capital
351.15350.97335.64330.06241-
Retained Earnings
-324.97-321.04-308.08-293.8-181.13-
Comprehensive Income & Other
-10.63-10.63-10.61-10.62-10.36-
Total Common Equity
15.5519.3116.9525.6449.51-
Shareholders' Equity
16.8620.6218.2626.9549.51-
Total Liabilities & Equity
20.2223.9822.6530.1656.82-
Total Debt
----0.19-
Net Cash (Debt)
19.2822.8521.6128.7952.89-
Net Cash Growth
-40.45%5.75%-24.94%-45.57%--
Net Cash Per Share
3.234.155.9717.3749.69-
Filing Date Shares Outstanding
5.535.495.433.731.061.06
Total Common Shares Outstanding
5.515.483.742.661.061.06
Working Capital
16.4720.2218.1426.9549.27-
Book Value Per Share
2.823.524.549.6645.97-
Tangible Book Value
15.5519.3116.9525.6449.51-
Tangible Book Value Per Share
2.823.524.549.6645.97-
Machinery
-0.150.140.050.14-
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q